CRP and renal cell carcinoma: Many pretreatment blood-based measurements of systemic inflammatory response are prognostic in patients with RCC, including NLR [6], CRP [7], MLR, GPS [12], granulocyte-to-dendritic cell (DC) ratio [11], neutrophilia [12], thrombocytosis, lymphopenia [13] and so on.